NCT01639560View on ClinicalTrials.gov

Varenicline for Light Smokers

PHASE4CompletedINTERVENTIONAL

Enrollment

93

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions

Smoking

Interventions

DRUG

Varenicline

1 mg of varenicline twice per day for 12 weeks and brief behavioral counseling

DRUG

Placebo

1 placebo tablet twice per day for 12 weeks and brief behavioral counseling

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Mayo Clinic

OTHER

NCT01639560 - Varenicline for Light Smokers | Biotech Hunter | Biotech Hunter